Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF vs FTC/TDF in Adefovir-Experienced Chronic Hepatitis B
NCT00307489Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Gilead Sciences. Started Mar 2006; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT00307489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00307489.